Stoke Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Stoke Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2018 to Q3 2024.
  • Stoke Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending September 30, 2024 was 52.9M shares, a 19.5% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 52.9M +8.65M +19.5% Sep 30, 2024 10-Q 2024-11-05
Q2 2024 52.3M +8.1M +18.3% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 46.5M +2.32M +5.26% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 45.9M +6.48M +16.4% Dec 31, 2023 10-Q 2024-11-05
Q3 2023 44.3M +4.87M +12.3% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 44.2M +4.82M +12.2% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 44.2M +5.13M +13.1% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 39.4M +2.54M +6.88% Dec 31, 2022 10-K 2024-03-25
Q3 2022 39.4M +2.65M +7.19% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 39.4M +2.66M +7.24% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 39M +2.35M +6.4% Mar 31, 2022 10-Q 2022-05-10
Q4 2021 36.9M +325K +0.89% Dec 31, 2021 10-K 2023-03-06
Q3 2021 36.8M +3.42M +10.2% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 36.7M +3.51M +10.6% Jun 30, 2021 10-Q 2021-08-10
Q1 2021 36.7M +3.73M +11.3% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 36.6M +3.72M +11.3% Dec 31, 2020 10-K 2022-03-10
Q3 2020 33.4M +637K +1.95% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 33.2M +538K +1.65% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 33M Mar 31, 2020 10-Q 2020-05-15
Q4 2019 32.9M +32.1M +4418% Dec 31, 2019 10-K 2021-03-09
Q3 2019 32.7M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 32.7M Jun 30, 2019 10-Q 2019-08-14
Q4 2018 727K Dec 31, 2018 10-K 2020-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.